# High Dose Influenza Vaccine in Nursing Home - Pilot Study

> **NCT01720277** · PHASE4 · COMPLETED · sponsor: **Insight Therapeutics, LLC** · enrollment: 2957 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** HD Fluzone Vaccine
- **BIOLOGICAL:** SD Fluzone Vaccine

## Key facts

- **NCT ID:** NCT01720277
- **Lead sponsor:** Insight Therapeutics, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-05
- **Final completion:** 2016-05
- **Target enrollment:** 2957 (ACTUAL)
- **Last updated:** 2018-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720277, "High Dose Influenza Vaccine in Nursing Home - Pilot Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01720277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*